Penserra Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,884
| Closed | -$221K | – | 1261 |
|
|
2023
Q3 | $221K | Buy |
4,884
+1,023
| +26% | +$46.3K | ﹤0.01% | 714 |
|
|
2023
Q2 | $216K | Sell |
3,861
-1,319
| -25% | -$73.8K | ﹤0.01% | 770 |
|
|
2023
Q1 | $234K | Sell |
5,180
-100
| -2% | -$4.52K | ﹤0.01% | 662 |
|
|
2022
Q4 | $214K | Sell |
5,280
-2,812
| -35% | -$114K | ﹤0.01% | 675 |
|
|
2022
Q3 | $528K | Buy |
8,092
+6,412
| +382% | +$418K | 0.02% | 413 |
|
|
2022
Q2 | $102K | Sell |
1,680
-488
| -23% | -$29.6K | ﹤0.01% | 763 |
|
|
2022
Q1 | $136K | Buy |
+2,168
| New | +$136K | ﹤0.01% | 791 |
|
|
2020
Q4 | – | Sell |
-598
| Closed | -$50K | – | 1027 |
|
|
2020
Q3 | $50K | Buy |
+598
| New | +$50K | ﹤0.01% | 623 |
|